Preferred learners
- Anywhere
- Academic experience
Categories
Skills
Project scope
- What is the main goal for this project?
-
The main goal for the project is to build a competitive landscape for Bacchus Therapeutics and provide an analysis of the competitors in the biotech industry. This will involve understanding the current market position of Bacchus Therapeutics in relation to other companies in the biotech sector, identifying key competitors, and analyzing their strengths, weaknesses, opportunities, and threats.
- What tasks will learners need to complete to achieve the project goal?
-
- Research and compile a list of competitors in the biotech industry focusing on small molecule development for cancer treatment, especially kidney and liver cancers
- Analyze the market position of Bacchus Therapeutics in comparison to its competitors especially with high grade kidney and liver cancers.
- Identify the strengths, weaknesses, opportunities, and threats of each competitor in terms of market penetrance, insurance reimbursements, and incorporation in medical practice guidelines .
- Create a comprehensive report detailing the competitive landscape and analysis of the biotech companies in the cancer treatment sector.
- Present the findings and recommendations to the management team of Bacchus Therapeutics.
- What is the main goal for this project?
-
The main goal for the project is to build a competitive landscape for Bacchus Therapeutics and provide an analysis of the competitors in the biotech industry. This will involve understanding the current market position of Bacchus Therapeutics in relation to other companies in the biotech sector, identifying key competitors, and analyzing their strengths, weaknesses, opportunities, and threats.
- What tasks will learners need to complete to achieve the project goal?
-
- Research and compile a list of competitors in the biotech industry focusing on small molecule development for cancer treatment, especially kidney and liver cancers
- Analyze the market position of Bacchus Therapeutics in comparison to its competitors especially with high grade kidney and liver cancers.
- Identify the strengths, weaknesses, opportunities, and threats of each competitor in terms of market penetrance, insurance reimbursements, and incorporation in medical practice guidelines .
- Create a comprehensive report detailing the competitive landscape and analysis of the biotech companies in the cancer treatment sector.
- Present the findings and recommendations to the management team of Bacchus Therapeutics.
Supported causes
About the company
- https://www.linkedin.com/company/bacchus-therapeutics/?viewAsMember=true
- 2 - 10 employees
- Hospital, health, wellness & medical
Bacchus Therapeutics is a biotech company that exploits cancer’s hypermetabolic state by targeting specific cancer metabolic pathways. The aberrant expression of cancer-causing gene MYC is virtually unmatched, making MYC one of the most frequently deregulated genes in human tumors, including, liver, kidney, brain, blood, breast, prostate, and lung tumors. Human studies and preclinical models have established that dysregulation of MYC underlies the pathogenesis and aggressiveness of numerous cancers.
Based on our prior research at Stanford University, we developed innovative, proprietary small molecules that target fat metabolism. This causes regression of MYC cancers in preclinical mouse and human studies and prolongs survival. Moreover, our novel metabolomic platform allows us to screen which cancers will respond to our treatment. We are able to monitor therapeutic response within a few days of treatment by measuring the actual biomarkers of our cancer therapy. This allows us to tell patients and doctors if our drug is working much faster than for standard cancer treatments.